Evaluation of the Overall Quality of Life After the Neck Dissection Retro-spinal Sector (IIb), in Squamous Cell Carcinomas Clinical and Radiological N0 VADS

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02878655

Acronym

QDV2b

Enrollment

Registered

2016-08-25

Start date

2015-02-28

Completion date

2018-12-31

Last updated

2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SCCHN

Keywords

N0 clinical and radiological, dissection IIb sector

Brief summary

The nodal involvement in squamous cell carcinomas of the upper aerodigestive tract (VADS) is one of the main factors of poor prognosis, justifying the surgical management of neck dissection as a reference treatment. Under the influence of the American Hayes Martin, it was considered until the 1960s that over the intervention was, the greater the chance of recovery was. But has since been developed by the Argentine Osvaldo Suarez the concept of functional course, which consists of resection of lymph node tissue while retaining the main structures (muscles, nerves, vessels), as opposed to the recess radical which is reserved for the invasive metastasis. In addition to these notions, our job is to evaluate the quality of life of patients with SCCHN, N0 clinical and radiological, enjoying a functional neck dissection including IIb sector to support the approach which would be to stop the systematic inclusion of this territory.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with SCCHN histologically proven N0 clinical and radiological * Neoplastic Location: oral cavity, oropharynx, hypopharynx, larynx * Patient candidate for a neck dissection fonctonnel * Life expectancy\> 3 months * Stable patient not exhibiting at the time of recurrence sign of examination or other scalable neoplasia * Age over 18 ans * Patient was informed of the study * Patient fluent French

Exclusion criteria

* Patients with a history of malignancy, outside a basal cell cancer or cancer of the neck treated and cured * Patient has at the time of examination of recurrence of signs or other scalable neoplasia * Uncontrolled Infectious diseases * Neoadjuvant radiotherapy * Patient nursing or pregnant or lack of contraception during their reproductive * Intercurrent pathology involving life-threatening * Any medical or psychological condition associated that could compromise the patient's ability to participate in the study * Inability to submit to medical follow-up study for geographical, social or psychic

Design outcomes

Primary

Measure	Time frame	Description
Visual Annalogue Scale for Global Quality of Life	change over baseline and month 6	(rate between 0 and 10)

Countries

France

Contacts

Primary ContactRoger VIVIEN, MD

babin-e@chu-caen.fr

Backup ContactEmmanuel BABIN